Products from BPS Bioscience require a minimum order value above 400€
Encompassing Amino Acids: 31-692(end)
Application: SDS-PAGE and pull-down assays.
Background: PCSK9 (Proprotein convertase subtilisin/kexin type 9) functions as a negative regulator of hepatic low-density lipoprotein receptors (LDLRs) by binding to the LDLR ectodomain. The D374Y mutation is a gain of function mutation. The D374Y mutation is associated with hypercholesterolemia. This PCSK9 mutant is more potent at decreasing LDL uptake than wild-type PCSK9, most likely by increasing the binding affinity of PCSK9 for the LDLR. A deeper understanding of the function of this mutant protein and development of specific inhibitors may result in new therapeutic approaches for PCSK9 D374Y-linked diseases.
Description: Recombinant human PCSK9 (Human proprotein convertase subtilisin/kexin 9) encompassing amino acids 31-692, which comprise the protodomain, the catalytic, and the C-terminal domains. The construct contains a C-terminal His-tag (6xHis) followed by an Avi-tag™. The protein contains the potent gain of function D374Y mutation. The protein was affinity purified.
Format: Aqueous buffer solution.
Formulation: 8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol
Genbank: NM_174936
Host Cell Line: HEK293
Purity: ≥90%
Storage Stability: At least 6 months at -80°C.
Tags: C-terminal Avi-Tag™, His-Tag
Uniprot: Q8NBP7
Warnings: Avoid freeze/thaw cycles
Biosafety Level: Not applicable (BSL-1)
English
Deutsch
